Can colistin susceptibility results determined in multidrug resistant Gram-negative bacteria be used for polymyxin B?

[1] Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev. 2008; 21:449–65. LandmanD GeorgescuC MartinDA QualeJ Polymyxins revisited Clin Microbiol Rev 2008 21 449 65 Search in Google Scholar

[2] Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72:857–868. Koch-WeserJ SidelVW FedermanEB KanarekP FinerDC EatonAE Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy Ann Intern Med 1970 72 857 868 Search in Google Scholar

[3] Clinical and Laboratory Standards Institute (CLSI). M100. Performance Standards for Antimicrobial Susceptibility Testing. 2022; 32th ed, Wayne, PA. Available at: http://em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI%20M100%20ED32:2022&xormat=SPDF&src=BB (Accessed August 11, 2023). Clinical and Laboratory Standards Institute (CLSI) M100. Performance Standards for Antimicrobial Susceptibility Testing 2022 32th ed Wayne, PA Available at: http://em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI%20M100%20ED32:2022&xormat=SPDF&src=BB (Accessed August 11, 2023). Search in Google Scholar

[4] European Committee on Antimicrobial Susceptibility Testing. Break point tables for interpretation of MICs and zone diameters. 2023; Version 13.1, 2023. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.1_Breakpoint_Tables.pdf (Accessed August 11, 2023). European Committee on Antimicrobial Susceptibility Testing Break point tables for interpretation of MICs and zone diameters 2023 Version 13.1, 2023. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.1_Breakpoint_Tables.pdf (Accessed August 11, 2023). Search in Google Scholar

[5] Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [published correction appears in Clin Infect Dis. 2006; 42:1819. Dosage error in article text]. Clin Infect Dis. 2005;40:1333–1341. FalagasME KasiakouSK Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [published correction appears in Clin Infect Dis. 2006; 42:1819. Dosage error in article text] Clin Infect Dis 2005 40 1333 1341 Search in Google Scholar

[6] Clinical and Laboratory Standards Institute (CLSI). M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-tenth edition. 2015; Wayne, PA. Available at: https://clsi.org/media/1632/m07a10_sample.pdf (Accessed August 11, 2023). Clinical and Laboratory Standards Institute (CLSI) M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-tenth edition 2015 Wayne, PA Available at: https://clsi.org/media/1632/m07a10_sample.pdf (Accessed August 11, 2023). Search in Google Scholar

[7] ISO 20776-1:2019. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth microdilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. ISO, 2019. Available at: https://www.iso.org/obp/ui/en/#iso:std:iso:20776:-1:ed-2:v2:en (Accessed August 11, 2023). ISO 20776-1:2019 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth microdilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases ISO 2019 Available at: https://www.iso.org/obp/ui/en/#iso:std:iso:20776:-1:ed-2:v2:en (Accessed August 11, 2023). Search in Google Scholar

[8] Albur M, Noel A, Bowker K, Macgowan A. Colistin susceptibility testing: time for a review. J Antimicrob Chemother. 2014;69:1432–1434. AlburM NoelA BowkerK MacgowanA Colistin susceptibility testing: time for a review J Antimicrob Chemother 2014 69 1432 1434 Search in Google Scholar

[9] Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09). J Antimicrob Chemother. 2011;66:2070–2074. GalesAC JonesRN SaderHS Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006–09) J Antimicrob Chemother 2011 66 2070 2074 Search in Google Scholar

[10] Chew KL, La MV, Lin RTP, Teo JWP. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution. J Clin Microbiol. 2017;55:2609–2616. ChewKL LaMV LinRTP TeoJWP Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution J Clin Microbiol 2017 55 2609 2616 Search in Google Scholar

[11] Sader HS, Rhomberg PR, Farrell DJ, Jones RN. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide. Diagn Microbiol Infect Dis. 2015;83:379–381. SaderHS RhombergPR FarrellDJ JonesRN Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide Diagn Microbiol Infect Dis 2015 83 379 381 Search in Google Scholar

[12] Doymaz MZ, Karaaslan E. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Infect Dis (Lond). 2019;51:676–682. DoymazMZ KaraaslanE Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria Infect Dis (Lond) 2019 51 676 682 Search in Google Scholar

[13] Yıldız SS, Hekimoğlu CH, Bakkaloğlu Z, Alp E. Discrepancy between colistin and polymyxin B susceptibility results among Escherichia coli and Klebsiella pneumoniae clinical isolates [published online ahead of print, 2021 May 17]. Acta Microbiol Immunol Hung. 2021;10.1556/030.2021.01458. YıldızSS HekimoğluCH BakkaloğluZ AlpE Discrepancy between colistin and polymyxin B susceptibility results among Escherichia coli and Klebsiella pneumoniae clinical isolates [published online ahead of print, 2021 May 17] Acta Microbiol Immunol Hung 2021 10.1556/030.2021.01458 Open DOISearch in Google Scholar

[14] Humphries RM. Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy. 2015;35:22–27. HumphriesRM Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy 2015 35 22 27 Search in Google Scholar